Compare Nucor Corporation (NUE) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs Nuwellis Inc — how do they compare? Nucor Corporation trades at $250.33 (market cap $55.84B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Nucor Corporation is far larger — about 25381.8× Nuwellis Inc's market cap, and Nucor Corporation pays a 0.91% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nucor Corporation for 78 Days and Nuwellis Inc for 26 Days on average.
| NUE | NUWE | |
|---|---|---|
Market Cap | $55.84B | $2.20M |
Volume | 848,835 | 121,544 |
Sector | Basic Materials | Health |
52-Week High | $274.74 | $146.65 |
52-Week Low | $131.78 | $0.68 |
Typical Hold Time | 78 Days | 26 Days |
Enterprise Value | $60.25B | -$1.52M |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nucor (NUE) trades at $250.33, up 1.58% with a mixed technical picture showing bearish moving averages but neutral oscillators. The company delivered strong Q2 2026 earnings of $4.84 EPS, beating expectations, and projects higher Q3 earnings on improved steel pricing. Revenue has stabilized at $32.49B in 2025 after declines from 2022 peaks, with net margins improving to 7.99%. Analyst consensus remains positive with a $266.88 price target and 57.58% buy ratings.
Nucor presents a balanced opportunity with strong operational performance and shareholder returns through dividends, though facing headwinds from competitive pressures and cyclical steel demand. The stock's valuation appears reasonable with P/E of 19.64 and P/S of 1.56, but investors should monitor execution against Q3 guidance and industry capacity expansions.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
